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CYTOMEGALOVIRUS INFECTION IN PREGNANCY AND THE FETUS:          
A CASE PRESENTATION 
The  objective  of  this  case  study  was  to  study  possible  clinical 
manifestations  of  Human  Cytomegalovirus  (HCMV)  which 
demonstrate the vertical transmission of HCMV from mother to 
her  children.    The  patient,  an  HCMV  infected  woman  with 
chronic  socioeconomic  problems  and  depression,  was  observed 
between 2003 and 2011. During that time, five pregnancies were 
clinically monitored with use of immunograms, PCR, and general 
blood and urine analyses. This case showed that HCMV infection 
of pregnant mother caused death of newborns due to HCMV 
associated  complications.  Due  to  combinatory  therapy  the  fifth 
pregnancy was successful with delivery of a HCMV asymptomatic 
newborn. With the deficit of knowledge on HCMV and its effect 
on pregnant women in Uzbekistan, such research for the clinical 
manifestation of the virus is vital to deter the transmission of the 
virus and improve the wellbeing of both mother and child. 
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Introduction 
Cytomegalovirus (CMV) is one infection that is capable of “vertical” transmission from 
mother to infant, before, during or after birth. CMV may persist in a latent state, but 
under unfavorable conditions, is capable of causing a variety of pathological processes. 
Cytomegalovirus  transmission  also  occurs  “horizontally”  by  direct  person to person 
contact with virus containing bodily secretions and by transfusions of blood, leukocytes 
and platelets from infected donors (Pickering et al., 2009). 
Cytomegalovirus  localizes  favorably  in  the  salivary  glands  where  it  develops  in  the 
epithelial  cells,  and  in  the  kidneys.  Affected  cells  enlarge  and  develop  large  nuclear 
inclusions, which may acquire an “owl’s eye” appearance. The virus may remain in this 
state for a long time, secreted in urine and saliva. However, CMV can affect any cells of 
the body, thereby resulting in a polymorphic clinical picture.  
Once infected, the human may never be rid of CMV, although if the immune status is 
satisfactory viral replication may be suppressed, leading to a latent state. In this sense, the 
manifestations of CMV infection vary with the effectiveness of the immune response. 
This  clinical  case  demonstrates  clearly  the  insidious  and  aggressive  nature  of 
Cytomegalovirus (CMV) infection in the context of personal and social conditions similar 
to those described above. 
Case report 
In 2003 a 24 year old primigravida was referred to our clinical department with a twin 
pregnancy of 28 weeks gestation. Her initial visit to the referring gynecologist was late due 
to unfavorable social conditions and a complicated relationship with the husband’s family. 
A routine TORCH screen was performed, which revealed IgG antibodies to CMV and 
Herpes Simplex (HSV) Types 1 and 2. 
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WBC   2.3 x 109/L:  Monos   1%; Bands   1%; Segs   1%; Eos   0%;  
Lymphs   91%; ESR   32mm/h 
 
Urine Analysis: Yellow, turbid; Specific Gravity   1.020;  
WBCs   17 18 per field; Epithelial Cells   8 9 per field; Oxalates present;  
Casts   none 
 
A qualitative analysis for the CMV genome in blood plasma by polymerase chain reaction 
(PCR) was positive. The avidity index (IgG), an immunoassay, was less than 34%. This 
index  is  a  measure  of  the  binding  strength  of  the  antibody  with  the  antigen.  IgG 
immunoglobulins appear later than IgM immunoglobulins, which are elicited early in the 
primary immune response. IgG accumulates in large quantity and possesses high avidity.  
Detection in test serum of IgG antibody with an avidity index less than 30   35% indicates 
a  fresh  primary  infection.  A  level  greater  than  or  equal  to  40%  indicates  anamnestic 
antibodies of high avidity, evidencing past infection; a level in the range of 31   39% 
suggests a late stage of a primary infection or a recent recovery (Volodin et al., 2001). 
Thus,  the  determination  of  antibody  avidity  permits  the  differentiation  of  primary 
infection  from  reactivation  or  secondary  infection.  This  is  especially  important  for 
pregnant women, since primary CMV infection (and other TORCH infections) can lead to 
intrauterine defects, stillbirths, and other significant complications. 
The avidity index in this patient speaks not for primary infection, but for an insubstantial 
and deficient immune response. For treating this at risk pregnant patient, a supportive, 
supplementary metabolic treatment was instituted with the following: 
1.  A 10 day intravenous course of Inosine, a purine nucleoside precursor to adenosine 
triphosphate, 2% solution, 5 ml. in 250 ml. 0.9% NaCl; 
2.  A  10 day  intramuscular  course  of  Actovegin,  a  protein free  extract  of  calf  blood 
containing  essential  phospholipids  and  probiotics,  2.5  ml.  dissolved  in  5  ml.  0.9% 
NaCl; 
3.  As  an  immunomodulator,  Viusid  was  chosen,  considered  permissible  for  use  in 
pregnancy, from the second trimester. Viusid is a compound of glycyrrhizic acid and 
multivitamins, given orally. 
After  a  month  of  this  treatment,  the  patient  showed  slight  subjective  improvement. 
Analysis  of  blood  was  marginally  improved.  Unfavorable  circumstances  in  the  family 
prevented regular follow up at our center. 
The  delivery  of  twin  girls  occurred  at  37  weeks  gestation.  There  were  signs  of  early 
maturity and respiratory distress. One child expired on the sixth postnatal day; the other 
on the twenty first day of life. They were diagnosed with disseminated intrauterine CMV 
infection with bronchopneumonia. 
One year and seven months later the patient returned to our center pregnant. In the first 
trimester of this second pregnancy she appeared toxic with generalized weakness, malaise, 
nausea, vomiting, lower blood pressure (90/60 mm Hg) and mild hyperthermia (37.2   
37.8 degrees C). There was edema of the lower extremities. Bilateral lumbar flank pain was 
elicited on percussion. The blood plasma was positive for the genomes of CMV and HSV 
Types 1 and 2. Qualitative urine analysis was positive for protein and leukocytes and 
epithelial  cells  were  seen  in  large  quantities  throughout  the  microscopic  field  but  no 
crystals or casts. Urine specific gravity was 1.025. The serum creatinine was normal at 115 
 mol/L. Ultrasound scan was consistent with pyelonephritis. Her avidity index was still 
low  (however,  pertinent  to  this  patient  we  already  knew  that  this  was  not  a  primary 
infection).  Her  living  conditions  were  unchanged,  entailing  considerable  psychosocial 
stresses and a poor quality of life.  Medical and Health Science Journal / MHSJ  /  ISSN: 1804-1884 (Print) 1805-5014 (Online)   
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The second pregnancy continued under a constant threat of miscarriage. The uterus was 
in a tonic state, with a notable discharge containing some blood. Twice she was admitted 
to an outside obstetrical center. She was treated supportively with glucose and ascorbic 
acid, Inosine, and a prenatal multi vitamin, magnesium and vitamin B6. This pregnancy 
concluded in an emergency delivery of a 2800 gram baby girl born at term with Apgar 
scores of 3 and 5. In the early neonatal period the baby developed the first signs of 
disseminated  CMV  infection   interstitial  pneumonia,  respiratory  insufficiency,  and 
hepatitis. CMV genome was found in blood plasma and mononuclear cells. The neonate 
underwent resuscitative measures during which fresh blood, plasma and albumin were 
repeatedly transfused. With improvement in their general condition the mother and child 
were  discharged  home.  However  in  two  months  the  baby  was  re hospitalized  with 
bronchopneumonia,  hepatosplenomegaly,  elevated  transaminases,  renal  failure  and 
hyperthermia, consistent with disseminated CMV infection. The infant was transferred to 
intensive  care  at  the  Virology  Institute  for  further  supportive  treatment.  Initiation  of 
specific antiviral therapy was complicated by the evident hepatic and renal pathology, 
which  was  deemed  a  contraindication  to  Gancyclovir.  The  infant’s  status  improved 
somewhat,  and  she  was  released  home  on  the  45th  hospital  day.  However,  she  was 
hospitalized  again  10  days  later  with  hyperthermia  and  febrile  convulsions.  Elevated 
transaminasemia,  hyperbilirubinemia,  splenomegaly  were  noted,  and  urine  analysis 
revealed a large number of fresh RBCs. Despite resuscitative measures the infant expired 
at five months of age. 
The third pregnancy for this woman came five months after the death of the third child. 
The entire pregnancy passed under threat of spontaneous abortion. Qualitative plasma 
analysis for CMV remained positive; iron deficiency anemia persisted. She manifested 
generalized weakness, fatigability and depression. Psychosocial living conditions remained 
unsatisfactory.  In  view  of  her  prior  experience  with  pregnancies,  she  was  offered  an 
elective Caesarean section to mitigate the risk of intrapartum infection.  
An  infant  boy  was  delivered  by  C section  with  Apgar  scores  of  8  and  9,  and  was 
immediately put to breast. Outwardly the infant seemed healthy. Mother and child were 
discharged from the obstetrical service on the seventh day.  
The infant was followed on a daily basis. At 8   9 days, there were no external signs, but 
on pulmonary auscultation there were coarse breath sounds. On the tenth day, abrupt, 
fulminating respiratory insufficiency developed. He was admitted on an emergency basis 
to the Virology Institute intensive care unit, where he expired on the twelfth day of life. 
An autopsy revealed an underdeveloped, rudimentary thymus gland, pulmonary edema, 
and cerebral edema.  
This patient had a fourth pregnancy, which ended in a spontaneous abortion at eight 
weeks. 
The woman experienced a long period of depression, and overall fatigue and weakness 
during  the subsequent  eight  months.  Psychologists  were  called  to  assist  her  after  she 
attempted suicide.  
Further  therapeutic  interventions  were  directed  at,  first  of  all,  improving  her  social 
conditions, then conducting treatments and rehabilitation. Periodically during two years 
the  patient  received  various  supportive  metabolic  treatments,  such  as  probiotics, 
membrane  stabilizers,  preparations  affecting  lipid  metabolism,  essential  phospholipids, 
and  detoxifiers.  Unfortunately,  optimal  specific  anti viral  therapy  was  not  considered 
possible.  In Uzbekistan the antiviral Gancyclovir, considered specific treatment for CMV, 
is extraordinarily expensive, and as a result is not accessible for many patients in need of it. 
Our patient fell into this category. Conditions dictated a combined approach to treat the 
viral infection and support the patient. How we purported to act was well expressed by 
Andrewes (1967), that antibiotics can achieve swift sterilizing effects in many infectious 
diseases, but in others, for example, those caused by herpesviruses, complete elimination 
of the infectious agent is impossible, and further treatment is accomplished by mobilizing 
immune factors, which takes time. Medical and Health Science Journal / MHSJ  /  ISSN: 1804-1884 (Print) 1805-5014 (Online)   
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We used a combined regimen, starting with intravenous Acyclovir, with inhibitory activity 
against  CMV.  Following  Acyclovir,  Polyoxidonium,  an  immunostimulant,  was 
administered IM daily in the upper outer gluteal quadrant for four days.  
Viusid, an inducer of endogenous interferon, was given orally one packet twice daily for 
three months. 
Improvement of the patient’s living conditions, medical treatment, and a long period of 
rehabilitation have given a good result.  
The fifth pregnancy appeared three years later, and proceeded favorably. In the entire 
course of the fifth pregnancy the CVM genome was measured positive once, following a 
common cold (URI). We were able to alleviate the pathological process with three courses 
of Viusid and Viferon, the latter a human recombinant interferon alpha 2b, administered 
as a rectal suppository. Delivery was by C section of a healthy girl, weighing 3.40 Kg, with 
Apgar scores of 9   10. 
Observation of the child over the first year demonstrated an absence of CMV genome in 
her blood, although up to three months of age IgG antibodies were detected by EIA. 
Since  the  CMV  genome  was  not  found  in  the  first  year,  and  at  6  months  IgG  had 
disappeared, we considered the immunoglobulins present in the child in the early months 
to be maternal antibody. Into her third year of life, the girl is developing normally, on a 
par with her peers both physically and mentally. 
It should be noted that in addition to an adequate treatment regimen, improvements in 
living conditions as well as normalization of the family situation played a signal role in the 
improvement  of  the  health  status  of  the  mother.  She  experienced  greater  success  in 
managing psychosocial stressors.  
Observation of the patient was conducted from 2003 till the present time. 
Conclusion 
Observation of the patient illustrated a number of aspects. The first aspect displayed is 
that the source of the intrauterine cytomegalovirus infection (CVMI) is the mother, ill 
with the acute form of CVMI or the latent chronic form in a period of reactivation. In 
such cases transmission to the fetus occurs directly through damaged placenta (prenatal), 
or  during  passage  through  the  birth  canal  (perinatal)  (Farber,  1989;  Kazantsev  and 
Popova,  1980).  Secondly,  detection  of  specific  anti CMV  IgG  in  the  newborn or  the 
infant up to one year of age suggests the transplacental transmission of antibodies from 
the infected mother. In this case we detected the viral DNA by PCR in both plasma and 
mononuclear cells.   Another aspect is that lifelong persistence of CMV virus is possible 
(Granitov,  2001).  Reactivation  of  the  infection  occurs  in  the  presence  of 
immunosuppression.  In  the  case  we  describe,  immunosuppression  had  taken  place, 
associated with a complex of factors: Firstly, the constant condition of stress; secondly, an 
inadequate  diet   unbalanced,  vitamin poor,  without  sufficient  protein;  iron deficiency 
anemia; a generalized weakening of the central nervous system.   Finally it was noted that 
in the presence of factors promoting immunosuppression and in intrauterine infection of 
the fetus, congenital cytomegalovirus disease can progress as the disseminated form, with 
injury of various organs and systems, as took place in all four of the cases of neonatal 
death presented here. 
With the deficit of knowledge on HCMV and its effect on pregnant women and their 
children in Uzbekistan, such research into the clinical manifestation of the virus is vital to 
help deter the transmission of the virus, improve the wellbeing of mother and child, and 
prevent miscarriage and death of the child.  Such knowledge is vital due to such a high 
percentage of the population being infected with the virus.  Treatment can be maximally 
effective  in  a  setting  of  combined  specific  antiviral  and  supportive  pathophysiological 
therapy, together with psychosocial treatment and personal health education. In addition, 
public information through the media on all aspects of infectious disease prevention is 
needed to improve public hygienic habits and the quality of life.  Further research of Medical and Health Science Journal / MHSJ  /  ISSN: 1804-1884 (Print) 1805-5014 (Online)   
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Cytomegalovirus possible clinical manifestation is encouraged along with research into 
optimal treatment for the virus.  
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